Literature DB >> 28782978

Smoking Consequences Questionnaire: A reevaluation of the psychometric properties across two independent samples of smokers.

Lorra Garey1, Kara Manning1, Charles Jardin1, Adam M Leventhal2, Matthew Stone2, Amanda M Raines3, Raina D Pang2, Clayton Neighbors1, Norman B Schmidt3, Michael J Zvolensky1.   

Abstract

Drug use outcome expectancies are a central construct to psychosocial theories of addictive disorders. In tobacco literature, the Smoking Consequences Questionnaire (SCQ; Brandon & Baker, 1991) is a tool used to assess this construct. Despite its common use, the SCQ has received little psychometric evaluation. In the current report, samples from 2 studies were used to examine the assumed SCQ structure, develop a novel truncated scale, and evaluate the psychometric properties of the novel scale. In Study 1, the 4-factor SCQ structure was examined using data from 343 (32.4% female; Mage = 43.7; SD = 10.8) adult nontreatment-seeking smokers. Results from Study 1 indicated that the 4-factor SCQ structure did not adequately explain covariance between items. Instead, results provided evidence for a 5-factor structure that tapped into outcome expectancies related to (a) immediate negative consequences (IC), (b) long-term negative consequences (LTC), (c) sensory satisfaction (SS), (d) negative affect reduction, and (e) appetite-weight control (AW). In Study 2, the 5-factor structure of the SCQ was confirmed and the construct validity was evaluated in 582 (48.2% female; Mage = 36.9; SD = 13.5) treatment-seeking adult smokers. Study 2 found evidence for measurement invariance across sex and overtime of the 5-factor structure as well as substantial construct validity. Results from 2 independent samples challenge the traditional 4-factor model of the SCQ, and instead, provide evidence for a novel 5-factor SCQ structure with strong validity and reliability. Alternate scoring algorithms for the SCQ, including a 5-subscale scheme, warrant consideration to ensure optimal measurement precision and construct differentiation. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 28782978      PMCID: PMC5803479          DOI: 10.1037/pas0000511

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  61 in total

1.  Dysphoria and smoking among treatment seeking smokers: the role of smoking-related inflexibility/avoidance.

Authors:  Julia D Buckner; Samantha G Farris; Michael J Zvolensky; Sonia M Shah; Adam M Leventhal; Jennifer A Minnix; Norman B Schmidt
Journal:  Am J Drug Alcohol Abuse       Date:  2014-11-14       Impact factor: 3.829

2.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

3.  A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68).

Authors:  Megan E Piper; Thomas M Piasecki; E Belle Federman; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker
Journal:  J Consult Clin Psychol       Date:  2004-04

4.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Authors:  Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

5.  Development and validation of an adolescent smoking consequences questionnaire.

Authors:  Johanna M Lewis-Esquerre; James R Rodrigue; Christopher W Kahler
Journal:  Nicotine Tob Res       Date:  2005-02       Impact factor: 4.244

6.  Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse.

Authors:  Chad J Gwaltney; Saul Shiffman; Mark H Balabanis; Jean A Paty
Journal:  J Abnorm Psychol       Date:  2005-11

7.  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence.

Authors:  C S Pomerleau; S M Carton; M L Lutzke; K A Flessland; O F Pomerleau
Journal:  Addict Behav       Date:  1994 Jan-Feb       Impact factor: 3.913

8.  Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Nancy C Jao
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

9.  A prospective study of the Acquired Preparedness Model: the effects of impulsivity and expectancies on smoking initiation in college students.

Authors:  Neal Doran; Rubin Khoddam; Patricia E Sanders; C Amanda Schweizer; Ryan S Trim; Mark G Myers
Journal:  Psychol Addict Behav       Date:  2012-06-11

10.  Anxiety sensitivity and smoking motives and outcome expectancies among adult daily smokers: replication and extension.

Authors:  Teresa M Leyro; Michael J Zvolensky; Anka A Vujanovic; Amit Bernstein
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

View more
  4 in total

1.  Sex differences in smoking constructs and abstinence: The explanatory role of smoking outcome expectancies.

Authors:  Lorra Garey; Natalia Peraza; Tanya Smit; Nubia A Mayorga; Clayton Neighbors; Amanda M Raines; Norman B Schmidt; Michael J Zvolensky
Journal:  Psychol Addict Behav       Date:  2018-09

2.  Situational fears: Association with negative affect-related smoking cognition among treatment seeking smokers.

Authors:  Jafar Bakhshaie; Andrew H Rogers; Brooke Y Kauffman; Melissa Fasteau; Julia D Buckner; Norman B Schmidt; Michael J Zvolensky
Journal:  Addict Behav       Date:  2018-06-09       Impact factor: 3.913

3.  Health-risk Behaviors and Type 1 Diabetes Outcomes in the Transition from Late Adolescence to Early Emerging Adulthood.

Authors:  Eunjin Lee Tracy; Cynthia A Berg; Ashley C Baker; Daniel Mello; Michelle L Litchman; Deborah J Wiebe
Journal:  Child Health Care       Date:  2018-10-22

4.  The synergetic effect of alcohol consumption and cigarettes per day on smoking outcomes expectancies among Latinx adult smokers.

Authors:  Ruben Rodriguez-Cano; Lorra Garey; Jafar Bakhshaie; Justin M Shepherd; Michael J Zvolensky
Journal:  J Ethn Subst Abuse       Date:  2020-09-11       Impact factor: 1.331

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.